Showing 301 - 320 results of 2,687 for search '"chemotherapy"', query time: 0.06s Refine Results
  1. 301
  2. 302
  3. 303

    Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study by Yuchen Wang, Xiaobo Ma, Kewei Ma, Xi Chen, Hua He, Xiangye Zhao, Mengge Fan, Yinghui Xu

    Published 2025-01-01
    “…Patients receiving neoadjuvant chemoimmunotherapy (NCI) show improved pathological responses and disease-free survival (DFS) compared to those receiving Neoadjuvant chemotherapy (NC). However, there is still no consensus on the treatment for potentially resectable stage IIIA/IIIB NSCLC.MethodsThis retrospective study included 71 patients newly diagnosed with stage III NSCLC at our institution between 2017 and 2023: 46 patients received NCI and 25 patients received NC followed by surgical resection. …”
    Get full text
    Article
  4. 304

    Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases by Zensen Sebastian, Steinberg-Vorhoff Hannah L, Milosevic Aleksandar, Richly Heike, Siveke Jens T, Opitz Marcel, Haubold Johannes, Li Yan, Forsting Michael, Schaarschmidt Benedikt Michael

    Published 2024-11-01
    “…In uveal melanoma patients, short-term evaluation of treatment response to hepatic artery infusion chemotherapy (HAIC) using the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria is challenging due to the diffuse metastatic spread. …”
    Get full text
    Article
  5. 305

    First-line chemotherapy with tislelizumab for patients with extensive-stage small cell lung cancer: a cost-effectiveness analysis by Rong Long, Fangping Chen

    Published 2024-12-01
    “…Abstract The Phase 3 RATIONALE-312 trial (NCT04005716) showed that tislelizumab plus chemotherapy led to a noteworthy enhancement resulted in a significant improvement in overall survival among patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) compared to chemotherapy alone. …”
    Get full text
    Article
  6. 306
  7. 307
  8. 308

    Systematic Evaluation of Clinical Efficacy of Shiyiwei Shenqi (Ginseng and Astraglus, Eleven Ingredients) Preparation in Adjuvant Chemotherapy for Malignant Tumor by Bowei HUANG, Yuhui ZENG, Lisha LU, Huijuan GAN

    Published 2021-04-01
    “…Objective:To evaluate the clinical efficacy and safety of Shiyiwei Shenqi preparation adjuvant chemotherapy in the treatment of malignant tumors by Meta analysis.Methods:Data were search from the databases of CBM, CNKI, Wanfang Data, VIP, PubMed, Web of Science, Cochrane Library and EMbase. …”
    Get full text
    Article
  9. 309
  10. 310

    Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy by Gu W, Tang J, Liu P, Gan J, Lai J, Xu J, Deng J, Liu C, Wang Y, Zhang G, Yu F, Shi C, Fang K, Qiu F

    Published 2025-01-01
    “…The calibration curve showed that the established nomogram could well predict the survival based on these covariates.Conclusion: The AA-G3 with IDH-1 wildtype, MGMT unmethylation or 1p/19q non-codeletion patients was resistant to radiotherapy and chemotherapy, has a poor prognosis and needs a more active treatment.Keywords: glioma, radiotherapy, prognosis, nomogram…”
    Get full text
    Article
  11. 311
  12. 312

    Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With Cancer by Ciao-Sin Chen, Michael P Dorsch, Sarah Alsomairy, Jennifer J Griggs, Reshma Jagsi, Michael Sabel, Amro Stino, Brian Callaghan, Daniel L Hertz

    Published 2025-02-01
    “… BackgroundChemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating adverse effect of neurotoxic chemotherapy characterized by symptoms such as numbness, tingling, and weakness. …”
    Get full text
    Article
  13. 313
  14. 314

    Does Intraperitoneal Chemotherapy Increase the Incidence of Anastomotic Leakage after Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis by Yu Yang, Yuxuan Li, Xiaohui Du

    Published 2021-01-01
    “…To identify and evaluate the influence of intraperitoneal chemotherapy without hyperthermia (ICwh) to the incidence of anastomotic leakage (AL) after colorectal cancer surgery. …”
    Get full text
    Article
  15. 315

    Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China. by Chaoneng He, Xiufang Mi, Gaoqi Xu, Xinglu Xu, Wenxiu Xin, Like Zhong, Junfeng Zhu, Qi Shu, Luo Fang, Haiying Ding

    Published 2024-01-01
    “…<h4>Objective</h4>We aimed to investigate the cost-effectiveness of tislelizumab plus chemotherapy compared to chemotherapy alone as a first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (OSCC).…”
    Get full text
    Article
  16. 316
  17. 317
  18. 318
  19. 319

    Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence by Yuta Yamanaka, Yukiko Okuno, Keisuke Kamisako, Yuta Okazaki, Kentaro Nakanishi, Yume Sanada, Kiyori Yoshida, Tatsuki Ikoma, Yuki Takeyasu, Utae Katsushima, Hiroshige Yoshioka, Takayasu Kurata

    Published 2024-12-01
    “…ABSTRACT Introduction Extensive small cell lung cancer (ES‐SCLC) are currently managed using first‐line chemotherapy options, including atezolizumab (Atezo) plus etoposide and carboplatin (CE) or durvalumab (Durva) plus etoposide with either cisplatin (PE) or carboplatin (CE). …”
    Get full text
    Article
  20. 320